Bibliography
- LI F, GOILA-GAUR R, SALZWEDEL K et al.: PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Nati Acad. Sci. USA (2003) 100(23):13555–13560.
- HASTINGS JC, SELNICK H, WOLANSKI B, TOMASSINI JE: Antivirus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob. Agents Chemother. (1996) 40(5):1304–1307.
- SHAW-REID CA, MUNSHI V, GRAHAM P et al.: Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien 22,4dioxobutanoic acid. J. Biol. Chem. (2003) 278(5):2777–2780.
- HAZUDA DJ, FELOCK P, WITMER M et al.: Inhibitors of strand transfer that integration and inhibit HIV-1 replication in cells. Science (2000) 287(5453):646–650.
- SUMMA V, PETROCCHI A, PACE P et al.: Discovery of a,y-diketo acids as potent selective and reversible inhibitors of hepatitis C virus N55b RNA-dependent RNA polymerase. ./. Med. Chem. (2004). 47(1):14–17.
- GOLDSCHMIDT V, MARQUET R Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs). kit. .j Biochem. Cell Biol. (2004) 36(9):1687–1705.
- ROOT MJ, KAY MS, KIM PS: Protein design of an HIV-1 entry inhibitor. Science (2001) 291(5505):884–888.
- GOD OFSKY E, AFDHAL N, RUSTGI V et al.: First clinical results for a novel antiviral treatment for hepatitis C: a ( I/II dose escalation trial assessing tolerance, pharmacokinetics, and antiviral activity of NM283. Hepatol (2004) 40\(Suppl. 1):35.
- LAMARRE D, ANDERSON PC, BAILEY M et al.: An N53 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature (2003) 426(6963):186–189.